US 10759855
Antigen binding molecules to TIGIT
granted A61PA61P1/00A61P17/06
Quick answer
US patent 10759855 (Antigen binding molecules to TIGIT) held by Rigel Pharmaceuticals, Inc. expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P1/00, A61P17/06, A61P19/02, A61P31/18